Related Experiment Video
Updated: Jun 4, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Concordance between Hemoglobin and Hematocrit among Children and Pregnant Persons in National Health and Nutrition
Maren E Wolf1, Maria Elena D Jefferds2, Lisa D Gardner2
1Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, United States; International Micronutrient Malnutrition Prevention and Control Program, Nutrition Branch, Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Insights
Hemoglobin and hematocrit show significant disagreement in identifying anemia in children and pregnant individuals. This discordance risks missed diagnoses and untreated anemia, potentially leading to adverse outcomes.
Area of Science:
- Clinical diagnostics
- Biomarker analysis
- Pediatric and obstetric health
Background:
- Hemoglobin and hematocrit are primary anemia biomarkers.
- Discrepancies between these biomarkers can impact anemia identification.
Purpose of the Study:
- To assess the agreement between hemoglobin and hematocrit for anemia detection.
- Focus on children aged 1 to <5 years and pregnant individuals.
Main Methods:
- Analysis of National Health and Nutrition Examination Survey data (1999-2020).
- Utilized CDC anemia cutoff values, adjusting for pregnancy status and smoking.
- Employed Cohen's kappa to measure concordance across sociodemographic groups.
Main Results:
- Anemia prevalence was higher when using hematocrit compared to hemoglobin in both children and pregnant persons.
- Concordance (kappa scores) ranged from weak to moderate (0.53–0.78).
- Approximately 50% of children and 40% of pregnant individuals were identified by only one biomarker.
Conclusions:
- Substantial discordance exists between hemoglobin and hematocrit in anemia diagnosis.
- Interchangeable use of these biomarkers may lead to missed anemia cases.
- Untreated anemia poses risks for adverse pregnancy, birth, and developmental outcomes.
Background:
Hemoglobin and hematocrit are the 2 most common biomarkers used to identify anemia in clinical settings, but their results do not always agree.
Objectives:
To examine agreement between hemoglobin and hematocrit in identifying anemia among children aged 1 to <5 y and pregnant persons.
Methods:
Pregnant persons and children aged 1 to <5 y with hemoglobin and hematocrit results from the same whole blood sample in National Health and Nutrition Examination Survey (1999-2020) were included. We used the Centers for Disease Control and Prevention anemia cutoff values for children, pregnancy status, trimester, and smoking adjustments. We examined concordance of anemia, sensitivity, and specificity among those with anemia based on ≥1 test overall and by race/ethnicity, sex, and income level. Cohen's kappa was used to measure concordance.
Results:
Analytic samples included 7052 children and 1437 pregnant persons, of whom 1119 had trimester data. Among children, anemia prevalence was 3.7% [95% confidence interval (CI): 3.1, 4.3] based on hemoglobin and 5.5% (95% CI: 4.7, 6.3) based on hematocrit. Among pregnant persons, anemia prevalence was 7.7% (95% CI: 5.9, 9.5) based on hemoglobin and 12.4% (95% CI: 10.1, 14.6) based on hematocrit. Kappa scores overall and by sociodemographic characteristics ranged from 0.64 to 0.75 (moderate concordance) among children and from 0.53 to 0.78 (weak to moderate concordance) among pregnant persons. Among those with anemia on ≥1 test, 53.5% of children and 61.5% of pregnant persons had anemia based on both tests.
Conclusions:
We found substantial discordance between the 2 biomarkers; ∼50% of children and 40% of pregnant women were identified by only 1 of the 2 biomarkers. Because hemoglobin and hematocrit may be used interchangeably in the clinical setting, individuals with anemia may be missed, not receive treatment, and therefore be at higher risk of adverse pregnancy, birth, and developmental outcomes.
Related Concept Videos
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Hemoglobin
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Hematopoiesis
Oxygen Transport in the Blood
Rh Blood Group
Test for Homogeneity

